angiotensin ii has been researched along with Cachexia in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kakar, SS; Straughn, AR | 1 |
| Bertoldi, G; Calò, LA; Davis, PA; Gobbi, L; Pagnin, E; Ravarotto, V; Rigato, M | 1 |
| Kashiwase, Y; Minami, K; Miyano, K; Nonaka, M; Terawaki, K; Ueta, Y; Uezono, Y; Uzu, M; Yanagihara, K; Yokoyama, T | 1 |
| Delafontaine, P; Galvez, S; Higashi, Y; Mitch, WE; Sukhanov, S; Tabony, AM; Yoshida, T | 1 |
| Delafontaine, P; Yoshida, T | 2 |
| Scherrer-Crosbie, M | 1 |
| Gagnon, B; MacDonald, N; Murphy, J; Penafuerte, CA; Sirois, J; Tremblay, ML | 1 |
| Delafontaine, P; Kapusta, DR; Semprun-Prieto, L; Sukhanov, S; Wainford, RD; Yoshida, T | 1 |
| Furuya, M; Inomata, N; Kangawa, K; Minamitake, Y; Ohsuye, K; Sugiyama, M; Yamaki, A | 1 |
| Delafontaine, P; Du, J; Li, Y; Mitch, WE; Rosenthal, N; Song, YH | 1 |
| Russell, ST; Sanders, PM; Tisdale, MJ | 1 |
| Andrade, FH; Balke, CW; Esser, KA; Reid, MB | 1 |
| Akao, M; Delafontaine, P | 1 |
| Date, Y; Hosoda, H; Kangawa, K; Koh, H; Kojima, M; Nagaya, N; Nakazato, M; Okumura, H; Oya, H; Shimizu, W; Uematsu, M; Yamagishi, M; Yutani, C | 1 |
5 review(s) available for angiotensin ii and Cachexia
| Article | Year |
|---|---|
Withaferin A: a potential therapeutic agent against COVID-19 infection.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Betacoronavirus; Cachexia; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Mice; Ovarian Neoplasms; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptor, Angiotensin, Type 1; RNA, Messenger; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Withanolides; Xenograft Model Antitumor Assays | 2020 |
Tracing angiotensin II's yin-yang effects on cardiovascular-renal pathophysiology.
Topics: Angiotensin II; Cachexia; Humans; Hypertension; Kidney; Renin-Angiotensin System | 2023 |
Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia.
Topics: Angiotensin II; Animals; Cachexia; Heart Diseases; Humans; Molecular Targeted Therapy; Muscle, Skeletal; Muscular Atrophy; Signal Transduction | 2013 |
Redox mechanisms of muscle dysfunction in inflammatory disease.
Topics: Angiotensin II; Animals; Antioxidants; Cachexia; Cytokines; Humans; Hypoxia; Muscle, Skeletal; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Signal Transduction | 2005 |
Angiotensin II as candidate of cardiac cachexia.
Topics: Angiotensin II; Cachexia; Heart Failure; Humans; Insulin-Like Growth Factor I; Muscle, Skeletal; Muscular Atrophy | 2006 |
1 trial(s) available for angiotensin ii and Cachexia
| Article | Year |
|---|---|
Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Body Mass Index; Cachexia; Chronic Disease; Energy Metabolism; Female; Ghrelin; Growth Hormone; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Peptide Hormones; Peptides; Predictive Value of Tests; Renin; Tumor Necrosis Factor-alpha | 2001 |
9 other study(ies) available for angiotensin ii and Cachexia
| Article | Year |
|---|---|
Modulation of synaptic inputs in magnocellular neurones in a rat model of cancer cachexia.
Topics: Angiotensin II; Animals; Cachexia; Cell Line, Tumor; Disease Models, Animal; Excitatory Postsynaptic Potentials; Male; Mannitol; Miniature Postsynaptic Potentials; Neoplasm Transplantation; Neoplasms; Neurons; Patch-Clamp Techniques; Rats; Supraoptic Nucleus | 2018 |
Mechanisms of Cachexia in Chronic Disease States.
Topics: Angiotensin II; Animals; Cachexia; Cell Proliferation; Chronic Disease; Cytokines; Humans; Muscle Proteins; Muscles; Muscular Atrophy; Oxidative Stress; Proteasome Endopeptidase Complex; Proteins; Regeneration; Renin-Angiotensin System; Signal Transduction; Ubiquitin | 2015 |
Losartan: A new treatment for cardiac cachexia?
Topics: Angiotensin II; Blood Pressure; Cachexia; Humans; Losartan; Myocardium; Neoplasms | 2015 |
Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia.
Topics: Angiotensin II; Biomarkers, Tumor; Cachexia; Case-Control Studies; Cohort Studies; Cytokines; Female; Humans; Male; Middle Aged; Neoplasms; Neutrophils; Peptide Hydrolases; RNA, Messenger | 2016 |
THE RENIN-ANGIOTENSIN SYSTEM AND THE BIOLOGY OF SKELETAL MUSCLE: MECHANISMS OF MUSCLE WASTING IN CHRONIC DISEASE STATES.
Topics: Angiotensin II; Animals; Cachexia; Chronic Disease; Humans; Mice; Muscle, Skeletal; Muscular Atrophy; Renin-Angiotensin System; Sarcopenia | 2016 |
Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus.
Topics: Angiotensin II; Animals; Cachexia; Cholecystokinin; Eating; Feeding Behavior; Gene Expression Regulation; Hypothalamus; Infusions, Intraventricular; Intracellular Signaling Peptides and Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuropeptide Y; Neuropeptides; Orexins; Phosphorylation; Time Factors | 2012 |
Ghrelin improves body weight loss and skeletal muscle catabolism associated with angiotensin II-induced cachexia in mice.
Topics: Adiposity; Angiotensin II; Animals; Cachexia; Cell Line; Feeding Behavior; Forkhead Box Protein O1; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression; Ghrelin; Humans; Insulin-Like Growth Factor I; Mice; Muscle Cells; Muscle Proteins; Muscle, Skeletal; SKP Cullin F-Box Protein Ligases; Tripartite Motif Proteins; Ubiquitin-Protein Ligases; Weight Loss | 2012 |
Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting.
Topics: Angiotensin II; Animals; Cachexia; Heart Failure; Insulin-Like Growth Factor I; Male; Mice; Mice, Transgenic; Muscle Proteins; Muscle, Skeletal; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; SKP Cullin F-Box Protein Ligases; TOR Serine-Threonine Kinases; Tripartite Motif Proteins; Ubiquitin-Protein Ligases; Vasoconstrictor Agents; Wasting Syndrome | 2005 |
Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cachexia; Cell Culture Techniques; Imidazolidines; Male; Mice; Muscle Fibers, Skeletal; Muscle Proteins; Muscle, Skeletal; Neoplasms; Proteasome Endopeptidase Complex; Ubiquitin | 2005 |